Академический Документы
Профессиональный Документы
Культура Документы
Electroconvulsive Therapy
Morgan & Mikhails
Anesthesia for electroconvulsive therapy: gui
delines for daily practice: 7AP111
Helsloot, D.; Lauweryns, J.
European Journal of Anaesthesiology (EJA).
29():106, June 2012.
ECT
Modified ECT including the use of Anaesthesia and
Muscle Relaxants.
The goal is to produce a therapeutic generalized seizure
3060 sec in duration.
Amount of current delivered is more important than
lenght of seizure.
Contraindications To ECT
Contraindications :
recent myocardial infarction (usually <3 months),
a recent stroke (usually <1 month), an intracranial
mass, or increased ICP from any cause.
Relative contraindications
include angina, poorly controlled heart failure,
significant pulmonary disease, bone fractures,
severe
osteoporosis, pregnancy, glaucoma, and retinal
detachment .
Physiological Response To
ECT
Central Nervous System
1. Increase in intracranial pressure
2. Increased regional cerebral blood flow, cerebral
oxygen consumption, and glucose utilization.
3. Increase in blood-brain barrier permeability.
4. Headache, confusion, and transient memory loss
are common in the immediate post-treatment
period.
Cardiovascular system
1. Initial brief parasympathetic response: lasts for 10-15seconds,
bradycardia, hypotension or even asystole may occur.
2. Sustained sympathetic response, peaking at 3-5 minutes,
associated with release of catecholamines, a rise in systolic
blood pressure (30-40%), and a rise in heart rate (more than
20%)(6)
3. Increased myocardial oxygen consumption.
4. The above effects predispose to cardiac dysrhythmias,
myocardial ischemia and infarction (especially with pre-existing
cardiac dysfunction).
5. Even in normal hearts, ventricular dysfunction has been noted
for up to 6 hrs after a treatment.
6. Very rarely, cardiac rupture has been reported.
Other Effects
1.
2.
3.
4.
5.
Preoperative Anaesthetic
Considerations
Assessment for the presence of ischemic heart
disease, cardiac failure, severe valvular heart
disease, uncontrolled hypertension, severe
chronic obstructive pulmonary disease, gastrooesophageal reflux and previous anaesthetic
history.
Any known allergies to drugs should be
documented.
Dentition should be thoroughly examined for
caries or loose teeth.
Any artificial work on the teeth e.g. crowns,
veneers, bridges, implants or intraosseous
denture supports should be documented.
Conduct Of Anesthesia
The aim is to provide a short duration of
unconsciousness and adequate muscle relaxation.
the return to consciousness should be rapid, and
full orientation is desirable.
Light general anesthesia with moderate degree of
muscular relaxation while minimizing the
aforementioned physiological and physical effect
Many anesthetic agents however have
anticonvulsant properties
The choice of drugs is therefore a balance between
providing adequate anesthesia without adversely
affecting the efficacy of ect
methohex
ital
propofol
thiopent
al
ketamin
e
midazola
m
etomidat
e
sevoflur
ane
class of
drugs
barbiturate
phenol
barbiturat
e
pencyclidi
ne
derivate
benzodiaz
epin
carboxyla
ted
imidazole
inhalation
agent
dose
0,5-1
mg/kg
1-1,5
mg/kg
(0,75-2)
1,5-2,5
mg/kg
2-4 mg/kg
(0,7-2,8)
0,5-5 mg
0,15-0,3
mg/kg
3,4%
onset
+++++
+++++
+++
++
+++
+++
siezure
threshol
d
seizure
duration
Opioid
Short-acting opioids, such as alfentanil, are not
given alone because they do not consistently
produce amnesia.
Alfentanil (10-20mcg/kg) or remifentanil
(1mcg/kg) can be used along with the induction
agent to increase the seizure duration and reduce
haemodynamic response.
Muscle Relaxants
Complete paralysis may be associatited prolonged apnea
The adequacy of muscle relaxation should be ascertained
before applying ect stimulus. these process is done by testing
for a reduction in deep tendon reflexs and muscle tone
It is not essential to have complete muscular paralysis.
Indeed, the reduced or modified muscular contractions in
response to the electrical stimulation, along with EEG
monitoring, are used to monitor seizure duration
A short-acting agent, such as succinylcholine (0.250.5
mg/kg), is most often selected.
Non-depolarising agents such as atracurium (0.3-0.5mg/kg),
mivacurium ((0.08-0.2mg/kg) or rocuronium (0.3- 0.6mg/kg),
can be used safely
Terimakasih